Michael C. Christensen
Valby, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Vortioxetine in Subgroups of Patients with Major Depressive Disorder and Early-Stage Dementia: Further Results from the MEMORY Study.
Journal: Neuropsychiatric disease and treatment
Published: June 23, 2025
Vortioxetine in the routine management of major depressive disorder: an analysis of European automated healthcare databases.
Journal: Current medical research and opinion
Published: May 17, 2025
Temporal glomerular gene expression dynamics during disease progression in a mouse model of hypertension-accelerated diabetic kidney disease.
Journal: Animal models and experimental medicine
Published: April 13, 2025
Analysis of reward behavior in patients with MDD and partial response to SSRI therapy treated with vortioxetine versus desvenlafaxine: Experience with the Effort-Expenditure for Rewards Task (EEfRT) in the VIVRE study.
Journal: Journal of affective disorders
Published: April 10, 2025
Deep learning-enhanced 3D imaging unveils semaglutide impact on cardiac fibrosis.
Journal: British journal of pharmacology
Published: March 05, 2025
Efficacy of vortioxetine versus desvenlafaxine in the treatment of functional impairment in patients with major depressive disorder: Results from the multinational VIVRE study.
Journal: CNS spectrums
Published: October 28, 2024
Effectiveness of Vortioxetine for the Treatment of Emotional Blunting in Patients with Major Depressive Disorder Experiencing Inadequate Response to SSRI/SNRI Monotherapy in Spain: Results from the COMPLETE Study.
Journal: Neuropsychiatric disease and treatment
Published: June 14, 2024
The Functioning Assessment Short Test (FAST): Clinically meaningful response threshold in patients with major depressive disorder receiving antidepressant treatment.
Journal: Journal of affective disorders
Published: March 15, 2024
Effectiveness of Vortioxetine in Working Patients with Major Depressive Disorder in China: A Subgroup Analysis of the RELIEVE China Study.
Journal: Neuropsychiatric disease and treatment
Published: February 27, 2024
Clinical benefits and bioequivalence of vortioxetine oral drop solution versus oral tablets.
Journal: Journal of psychopharmacology (Oxford, England)
Published: December 21, 2023
Goal Attainment Scaling for Depression: Validation of the Japanese GAS-D Tool in Patients with Major Depressive Disorder.
Journal: Neuropsychiatric disease and treatment
Published: October 19, 2023
Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population.
Journal: Neuropsychiatric disease and treatment
Published: August 14, 2023
Last Updated: 09/26/2026